Biohit Oyj (HEL:BIOBV)

Biohit Oyj Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	14.28	13.08	10.95	9.36	7.12
Revenue Growth (YoY)	9.23%	19.41%	16.98%	31.42%	-29.14%
Cost of Revenue	4.94	4.61	3.84	3.45	3.17
Gross Profit	9.34	8.46	7.11	5.92	3.96
Selling, General & Admin	4	4.09	3.63	3.45	3.06
Other Operating Expenses	2.44	2.19	1.87	1.98	2.07
Operating Expenses	6.78	6.64	5.98	7.42	7.13
Operating Income	2.56	1.83	1.13	-1.5	-3.17
Currency Exchange Gain (Loss)	-	0.03	-0.01	0.02	-0.01
Other Non Operating Income (Expenses)	0.56	0.41	-0.29	0.09	-0.16
EBT Excluding Unusual Items	3.12	2.26	0.83	-1.39	-3.34
Gain (Loss) on Sale of Investments	-0.25	-0.07	0.04	0.06	0.08
Gain (Loss) on Sale of Assets	-	-	-	0.02	-
Pretax Income	2.87	2.2	0.87	-1.31	-3.26
Income Tax Expense	0.3	0.34	0.27	0.2	0.05
Earnings From Continuing Operations	2.57	1.85	0.6	-1.5	-3.31
Net Income	2.57	1.85	0.6	-1.5	-3.31
Net Income to Common	2.57	1.85	0.6	-1.5	-3.31
Net Income Growth	38.74%	207.99%	-	-	-
Shares Outstanding (Basic)	15	15	15	15	15
Shares Outstanding (Diluted)	15	15	15	15	15
Shares Change (YoY)	0.58%	0.41%	0.13%	-	0.27%
EPS (Basic)	0.17	0.12	0.04	-0.10	-0.22
EPS (Diluted)	0.17	0.12	0.04	-0.10	-0.22
EPS Growth	41.15%	200.41%	-	-	-
Free Cash Flow	0.18	0.65	1.79	-0.48	-0.04
Free Cash Flow Per Share	0.01	0.04	0.12	-0.03	-0.00
Gross Margin	65.39%	64.73%	64.94%	63.19%	55.57%
Operating Margin	17.90%	13.96%	10.30%	-16.02%	-44.56%
Profit Margin	17.98%	14.16%	5.49%	-16.02%	-46.51%
Free Cash Flow Margin	1.29%	5.00%	16.34%	-5.10%	-0.56%
EBITDA	2.62	1.93	1.34	0.23	-1.39
EBITDA Margin	18.34%	14.78%	12.24%	2.46%	-19.51%
D&A For EBITDA	0.06	0.11	0.21	1.73	1.78
EBIT	2.56	1.83	1.13	-1.5	-3.17
EBIT Margin	17.90%	13.96%	10.30%	-16.02%	-44.56%
Effective Tax Rate	10.43%	15.67%	30.76%	-	-

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.